Literature DB >> 1718874

Epitope mapping of the alpha-toxin of Clostridium perfringens.

A J Logan1, E D Williamson, R W Titball, D A Percival, A D Shuttleworth, J W Conlan, D C Kelly.   

Abstract

A panel of monoclonal antibodies specific for the Clostridium perfringens alpha-toxin was produced by the fusion of X63.Ag8-653 cells with splenocytes from mice immunized either intrasplenically or intraperitoneally with an alpha-toxoid. The toxin-binding activity of each monoclonal antibody was evaluated. The monoclonal antibodies were also screened for their toxin-neutralizing potential in vitro, as determined by the inhibition of phospholipase C and hemolytic activities. In vivo inhibition of toxicity was assessed by the survival of mice challenged with preincubated alpha-toxin-antibody mixtures. Only one monoclonal antibody (3A4D10) was protective in vivo and neutralizing in both in vitro assays. Since 3A4D10 could inhibit both activities, the evidence suggests that these are colocated in the same area of the toxin molecule. This paper identifies a significant continuous linear binding region for 3A4D10 at positions 193 to 198 in the primary amino acid sequence of alpha-toxin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1718874      PMCID: PMC259046          DOI: 10.1128/iai.59.12.4338-4342.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  The biochemistry of bacterial toxins: The lecithinase activity of Cl. welchii toxins.

Authors:  M G Macfarlane; B C Knight
Journal:  Biochem J       Date:  1941-09       Impact factor: 3.857

2.  Virulence factors of Clostridium perfringens.

Authors:  L D Smith
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

3.  Cloning and sequencing of a phospholipase C gene of Clostridium perfringens.

Authors:  A Okabe; T Shimizu; H Hayashi
Journal:  Biochem Biophys Res Commun       Date:  1989-04-14       Impact factor: 3.575

4.  Clostridium perfringens exotoxins. I. Purification and properties of -toxin.

Authors:  K Mitsu; N Mitsui; J Hase
Journal:  Jpn J Exp Med       Date:  1973-04

5.  Isolation and function of a Clostridium perfringens enterotoxin fragment.

Authors:  Y Horiguchi; T Akai; G Sakaguchi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

7.  Intrasplenic primary immunization for the production of monoclonal antibodies.

Authors:  M Spitz; L Spitz; R Thorpe; E Eugui
Journal:  J Immunol Methods       Date:  1984-05-11       Impact factor: 2.303

8.  Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans.

Authors:  J Y Tso; C Siebel
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

9.  Molecular cloning and nucleotide sequence of the alpha-toxin (phospholipase C) of Clostridium perfringens.

Authors:  R W Titball; S E Hunter; K L Martin; B C Morris; A D Shuttleworth; T Rubidge; D W Anderson; D C Kelly
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

10.  Monoclonal antibodies against alpha toxin of Clostridium perfringens.

Authors:  H Sato; J Chiba; Y Sato
Journal:  FEMS Microbiol Lett       Date:  1989-05       Impact factor: 2.742

View more
  9 in total

1.  Epitope mapping of a monoclonal antibody against human thrombin by H/D-exchange mass spectrometry reveals selection of a diverse sequence in a highly conserved protein.

Authors:  Abel Baerga-Ortiz; Carrie A Hughes; Jeffrey G Mandell; Elizabeth A Komives
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

Review 2.  Bacterial phospholipases C.

Authors:  R W Titball
Journal:  Microbiol Rev       Date:  1993-06

3.  A live oral recombinant Salmonella enterica serovar typhimurium vaccine expressing Clostridium perfringens antigens confers protection against necrotic enteritis in broiler chickens.

Authors:  R R Kulkarni; V R Parreira; Y-F Jiang; J F Prescott
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

4.  A species-specific nucleotide sequence of Mycobacterium tuberculosis encodes a protein that exhibits hemolytic activity when expressed in Escherichia coli.

Authors:  S C Leão; C L Rocha; L A Murillo; C A Parra; M E Patarroyo
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis.

Authors:  Tran H Hoang; Huynh A Hong; Graeme C Clark; Richard W Titball; Simon M Cutting
Journal:  Infect Immun       Date:  2008-09-08       Impact factor: 3.441

6.  Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis.

Authors:  R R Kulkarni; V R Parreira; S Sharif; J F Prescott
Journal:  Clin Vaccine Immunol       Date:  2007-07-18

7.  Effect of phosphatidylcholine on the level expression of plc genes of Aspergillus fumigatus by real time PCR method and investigation of these genes using bioinformatics analysis.

Authors:  Ali Dehghan-Noodeh; Abdulshakor Nasir; Geoff David Robson
Journal:  Iran J Microbiol       Date:  2014-04

8.  The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.

Authors:  Evy Goossens; Stefanie Verherstraeten; Bonnie R Valgaeren; Bart Pardon; Leen Timbermont; Stijn Schauvliege; Diego Rodrigo-Mocholí; Freddy Haesebrouck; Richard Ducatelle; Piet R Deprez; Filip Van Immerseel
Journal:  Vet Res       Date:  2016-04-27       Impact factor: 3.683

9.  Toxin-neutralizing antibodies protect against Clostridium perfringens-induced necrosis in an intestinal loop model for bovine necrohemorrhagic enteritis.

Authors:  Evy Goossens; Stefanie Verherstraeten; Bonnie R Valgaeren; Bart Pardon; Leen Timbermont; Stijn Schauvliege; Diego Rodrigo-Mocholí; Freddy Haesebrouck; Richard Ducatelle; Piet R Deprez; Filip Van Immerseel
Journal:  BMC Vet Res       Date:  2016-06-13       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.